The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Preferred Dosing Schedule Pledged by HCV Drug Candidate

Back to News Homepage

Next

Minimize the Hepatitis Burden With Six Cleansing Foods

Decision Resources Predicts New Directions in HCV Therapy

March 26, 2010

Print this page

Based on currently available data and expert opinions, a research and advisory firm projects that the next decade will witness triple and quadruple therapies as the gold standard for treating Hepatitis C.

In 2013, the Telaprevir/peg-IFN-a-2a/ribavirin Regimen Will Earn Decision Resources’ Proprietary Clinical Gold Standard for Hepatitis C Virus Treatment-Naive Patients

In 2018, a Quadruple Therapy Regimen Will Likely Be Widely Used for the Treatment-Naive Patient Population, According to a New Report from Decision Resources

WALTHAM, Mass., March 25 /PRNewswire/ — Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, based on available data and expert opinion, the telaprevir/peg-IFN-a-2a/ribavirin* regimen will earn Decision Resources proprietary clinical gold-standard status for the treatment of hepatitis C virus (treatment-naive population) in 2013, following telaprevir’s approval for the indication in 2011.

The telaprevir/peg-IFN-a-2a/ribavirin regimen will earn gold standard status in 2013 owing to its competitive advantages in efficacy and delivery over all currently available hepatitis C virus therapies. In 2009, Decision Resources’ clinical gold standard for hepatitis C virus (treatment-naive population) was peg-IFN-a-2a/ribavirin.

Continue reading this entire article:
http://www.prnewswire.com/news-releases/in-2013-the-telaprevirpeg-ifn-a-2aribavirin-regimen-will-earn-decision-resources-proprietary-clinical-gold-standard-for-hepatitis-c-virus-treatment-naive-patients-89119027.html

No Comments - be the first!
Share
Share

Previous

Preferred Dosing Schedule Pledged by HCV Drug Candidate

Back to News Homepage

Next

Minimize the Hepatitis Burden With Six Cleansing Foods

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.